V.B. Desai Financial [VBDESAI] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison
V.B. Desai Financial
BSE
Loading...
Suven Life Sciences
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: V.B. Desai Financial wins in 9 metrics, Suven Life Sciences wins in 7 metrics, with 1 ties. V.B. Desai Financial appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | V.B. Desai Financial | Suven Life Sciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.85 | -30.12 | Suven Life Sciences |
| Price-to-Book Ratio | 0.96 | 43.98 | V.B. Desai Financial |
| Debt-to-Equity Ratio | 0.00 | 0.00 | Tie |
| PEG Ratio | 0.31 | -0.36 | Suven Life Sciences |
| EV/EBITDA | 14.78 | -25.67 | Suven Life Sciences |
| Profit Margin (TTM) | 82.96% | 84.44% | Suven Life Sciences |
| Operating Margin (TTM) | 27.14% | -2,791.92% | V.B. Desai Financial |
| EBITDA Margin (TTM) | 27.14% | N/A | N/A |
| Return on Equity | 4.64% | -146.15% | V.B. Desai Financial |
| Return on Assets (TTM) | 4.42% | -118.91% | V.B. Desai Financial |
| Free Cash Flow (TTM) | $-83.48M | $-1.91B | V.B. Desai Financial |
| 1-Year Return | -15.93% | 48.25% | Suven Life Sciences |
| Price-to-Sales Ratio (TTM) | 4.10 | 672.95 | V.B. Desai Financial |
| Enterprise Value | $114.05M | $47.78B | Suven Life Sciences |
| EV/Revenue Ratio | 4.03 | 635.66 | V.B. Desai Financial |
| Gross Profit Margin (TTM) | 87.69% | 100.00% | Suven Life Sciences |
| Revenue per Share (TTM) | $6 | $0 | V.B. Desai Financial |
| Earnings per Share (Diluted) | $1.23 | $-8.45 | V.B. Desai Financial |
| Beta (Stock Volatility) | N/A | 0.86 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
V.B. Desai Financial vs Suven Life Sciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| V.B. Desai Financial | -1.83% | -1.23% | -8.04% | -22.93% | -11.21% | -19.41% |
| Suven Life Sciences | 1.46% | 1.07% | -3.67% | -13.79% | 98.12% | 75.60% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| V.B. Desai Financial | -15.93% | -15.93% | -15.93% | 217.94% | -11.83% | 63.43% |
| Suven Life Sciences | 48.25% | 199.11% | 297.93% | -9.55% | 650.02% | 3,355.85% |
News Based Sentiment: V.B. Desai Financial vs Suven Life Sciences
V.B. Desai Financial
News based Sentiment: POSITIVE
The company reported strong financial performance for FY2025, including debt-free status, revenue growth, and improved asset base. The stock price surge on September 3rd indicates positive market reaction, although subsequent fluctuations require monitoring. Overall, the month's developments suggest a strengthening investment case.
Suven Life Sciences
News based Sentiment: MIXED
September presented a mixed picture for Suven Life Sciences. While the company continues to struggle financially, with increasing losses and a high valuation premium, the upcoming clinical data presentation and positive share price movement suggest potential for future growth. This creates a high-risk, high-reward scenario for investors.
Performance & Financial Health Analysis: V.B. Desai Financial vs Suven Life Sciences
| Metric | VBDESAI | SUVEN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹116.10M | ₹49.69B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,142 | 125,280 |
| 90 Day Avg. Volume | 1,266 | 133,944 |
| Last Close | ₹25.75 | ₹224.63 |
| 52 Week Range | ₹17.00 - ₹44.64 | ₹102.50 - ₹299.99 |
| % from 52W High | -42.32% | -25.12% |
| All-Time High | ₹245.00 (Jan 14, 2008) | ₹338.50 (Apr 13, 2015) |
| % from All-Time High | -89.49% | -33.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.36% | 0.86% |
| Quarterly Earnings Growth | 0.25% | 0.86% |
| Financial Health | ||
| Profit Margin (TTM) | 0.83% | 0.84% |
| Operating Margin (TTM) | 0.27% | -27.92% |
| Return on Equity (TTM) | 0.05% | -1.46% |
| Debt to Equity (MRQ) | 0.00 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹26.73 | ₹5.04 |
| Cash per Share (MRQ) | N/A | ₹2.75 |
| Operating Cash Flow (TTM) | ₹-81,928,000 | ₹-1,590,282,000 |
| Levered Free Cash Flow (TTM) | ₹5.59M | ₹-1,607,450,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: V.B. Desai Financial vs Suven Life Sciences
| Metric | VBDESAI | SUVEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.85 | -30.12 |
| Forward P/E | 0.00 | 11.47 |
| PEG Ratio | 0.31 | -0.36 |
| Price to Sales (TTM) | 4.10 | 672.95 |
| Price to Book (MRQ) | 0.96 | 43.98 |
| Market Capitalization | ||
| Market Capitalization | ₹116.10M | ₹49.69B |
| Enterprise Value | ₹114.05M | ₹47.78B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.03 | 635.66 |
| Enterprise to EBITDA | 14.78 | -25.67 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.86 |
| Book Value per Share (MRQ) | ₹26.73 | ₹5.04 |
Financial Statements Comparison: V.B. Desai Financial vs Suven Life Sciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VBDESAI | SUVEN |
|---|---|---|
| Revenue/Sales | ₹9.65M | ₹18.67M |
| Cost of Goods Sold | ₹1.19M | ₹0 |
| Gross Profit | ₹8.46M | ₹18.67M |
| Research & Development | N/A | ₹414.88M |
| Operating Income (EBIT) | ₹5,000 | ₹-521.17M |
| EBITDA | ₹2.72M | ₹-501.49M |
| Pre-Tax Income | ₹2.70M | ₹-515.17M |
| Income Tax | ₹676,000 | ₹0 |
| Net Income (Profit) | ₹2.03M | ₹-515.17M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VBDESAI | SUVEN |
|---|---|---|
| Cash & Equivalents | ₹2.04M | ₹150.26M |
| Total Current Assets | ₹16.64M | ₹754.72M |
| Total Current Liabilities | ₹3.14M | ₹234.86M |
| Long-Term Debt | ₹0 | N/A |
| Total Shareholders Equity | ₹120.47M | ₹1.10B |
| Retained Earnings | N/A | ₹-6.01B |
| Property, Plant & Equipment | ₹356,000 | ₹756.69M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VBDESAI | SUVEN |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VBDESAI | SUVEN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,142 | 125,280 |
| Average Daily Volume (90 Day) | 1,266 | 133,944 |
| Shares Outstanding | 4.53M | 218.07M |
| Float Shares | N/A | 67.61M |
| % Held by Insiders | N/A | 0.69% |
| % Held by Institutions | N/A | 0.02% |
Dividend Analysis & Yield Comparison: V.B. Desai Financial vs Suven Life Sciences
| Metric | VBDESAI | SUVEN |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |